Clinical trials
Terminated Observational Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Castle Biosciences Incorporated | 1 |
| Precision Therapeutics | 1 |
| Stanford University | 1 |
| Telix Pharmaceuticals (Innovations) Pty Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 4 |
| Anus Neoplasms | 1 |
| Carcinoid Tumor | 1 |
| Carcinoma, Squamous Cell | 1 |
| Mesothelioma | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Rectal Neoplasms | 1 |
| Recurrence | 1 |
| Sarcoma | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.